Founded in 2013 and based in San Diego, California, Arcturus is a commercial mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR® mRNA technology (sa-mRNA) and (iii) mRNA drug substance along with drug Founded in 2013 and based in San Diego, California, Arcturus is a commercial mRNA medicines and vaccines company with enabling technologies: (i) LUNAR^® lipid-mediated delivery, (ii) STARR^® mRNA technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus developed KOSTAIVE^®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved.

Arcturus is a commercial mRNA medicines and vaccines company.

As one of the largest influenza vaccine providers globally, CSL Seqirus is a major contributor to the prevention of influenza and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., U.K. and Australia, and leading R&D capabilities, CSL Seqirus offers a portfolio of differentiated influenza vaccines in more than 20 countries around the world.
 
CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness.